Northwestern Medicine Dr. Alfred Baker 27th Annual Highlights of Recent Scientific Liver Meetings: Impact on Clinical Practice 2024

Advanced Hepatology Update on MASH, Liver Disease, Transplantation & Liver Cancer

The Northwestern Medicine Dr. Alfred Baker 27th Annual Highlights of Recent Scientific Liver Meetings: Impact on Clinical Practice 2024 provides a focused and clinically relevant review of the most important developments presented at major international hepatology conferences. Designed for clinicians involved in liver disease management, this course translates cutting-edge research into practical strategies that can be immediately applied in daily practice.

Held on November 23, 2024, at Northwestern Memorial Hospital in Chicago, this annual hepatology update highlights emerging diagnostic tools, evolving treatment paradigms, and evidence-based management approaches for a wide range of liver disorders, including Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol-Associated Liver Disease (ALD), portal hypertension, primary biliary cholangitis (PBC), hepatocellular carcinoma (HCC), and liver transplantation.

Through expert-led lectures and case-based discussions, participants gain valuable insights into recent scientific advances and their impact on modern hepatology practice.

Product Details

• Format: 7 Videos (.MP4) + 7 Audios (.MP3) + 7 Subtitle Files (.VTT) + 8 PDFs
• Total Size: 2.56 GB
• Course Date: November 23, 2024
• Location: Northwestern Memorial Hospital, Chicago, Illinois
• Access: On-Demand
• Level: Intermediate to Advanced

Program Overview

This annual liver conference distills key findings from leading hepatology meetings and focuses on translating emerging evidence into practical clinical care.

Major areas of emphasis include:

• Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• Alcohol-Associated Liver Disease (ALD)
• Non-invasive fibrosis assessment
• Portal hypertension
• Primary biliary cholangitis (PBC)
• Hepatocellular carcinoma (HCC)
• Liver transplantation
• Chronic liver disease management
• Advanced liver therapeutics
• Hepatology guideline updates

The curriculum is designed to help clinicians stay current with rapidly evolving standards of care in hepatology.

Learning Objectives

After completing this course, participants will be able to:

• Evaluate new non-invasive diagnostic tools for liver fibrosis assessment.
• Implement updated treatment strategies for MASH and metabolic liver disease.
• Apply current evidence-based approaches for Alcohol-Associated Liver Disease.
• Optimize management of portal hypertension and cirrhosis complications.
• Review emerging therapies for Primary Biliary Cholangitis.
• Integrate updated recommendations for liver cancer surveillance and treatment.
• Apply best practices in liver transplantation and post-transplant management.
• Utilize recent clinical trial data to improve patient outcomes.

Core Topics Covered

Metabolic Dysfunction-Associated Steatohepatitis (MASH)

A major focus of the course is the rapidly evolving field of metabolic liver disease.

Topics include:

• MASH diagnosis
• Risk stratification
• Fibrosis assessment
• Weight-loss interventions
• Emerging pharmacologic therapies
• Disease monitoring

Faculty review the latest evidence shaping the future of MASH management.

Non-Invasive Liver Fibrosis Assessment

The conference explores advances in:

• Elastography
• Fibrosis biomarkers
• Serum fibrosis panels
• Risk prediction models
• Disease progression monitoring

Participants learn how modern non-invasive testing is reducing reliance on liver biopsy.

Alcohol-Associated Liver Disease (ALD)

Sessions review:

• Alcohol-related hepatitis
• Cirrhosis management
• Abstinence strategies
• Addiction medicine integration
• Nutritional support
• Long-term disease monitoring

Experts discuss multidisciplinary approaches to improving outcomes in ALD.

Portal Hypertension & Cirrhosis

The program addresses:

• Portal hypertension management
• Variceal bleeding prevention
• Ascites treatment
• Hepatic encephalopathy
• Cirrhosis complications
• Updated clinical guidelines

Practical recommendations are emphasized throughout the course.

Primary Biliary Cholangitis (PBC)

Faculty discuss:

• Diagnostic criteria
• Risk stratification
• Ursodeoxycholic acid therapy
• Second-line treatments
• Emerging therapeutic options
• Long-term disease monitoring

Participants gain insight into current and future approaches to cholestatic liver disease.

Liver Malignancies

Dedicated sessions focus on:

• Hepatocellular carcinoma (HCC)
• Liver cancer surveillance
• Early detection strategies
• Imaging advances
• Systemic therapies
• Multidisciplinary oncology care

The course reviews evolving standards in liver cancer management.

Liver Transplantation

Topics include:

• Transplant evaluation
• Candidate selection
• Allocation updates
• Post-transplant care
• Recurrence prevention
• Long-term outcomes

Faculty provide updates on contemporary transplant hepatology practice.

Educational Features

✔ Highlights from Major International Liver Meetings

✔ Evidence-Based Hepatology Updates

✔ Non-Invasive Fibrosis Assessment Strategies

✔ MASH & Metabolic Liver Disease Advances

✔ Liver Cancer Surveillance and Treatment Updates

✔ Portal Hypertension Management

✔ Liver Transplantation Best Practices

✔ Practical Clinical Application

Target Audience

This course is ideal for:

• Hepatologists
• Gastroenterologists
• Transplant Hepatologists
• Internal Medicine Physicians
• Advanced Practice Providers
• Gastroenterology Fellows
• Hepatology Fellows
• Liver Disease Specialists

Why This Course Stands Out

✔ Summarizes key findings from leading hepatology conferences

✔ Focuses on clinically relevant updates

✔ Strong emphasis on MASH and metabolic liver disease

✔ Reviews emerging liver cancer therapies

✔ Covers modern fibrosis assessment technologies

✔ Practical guidance for transplant and cirrhosis management

✔ Ideal for busy clinicians seeking concise, high-yield hepatology updates

Clinical & Educational Value

The Northwestern Medicine Dr. Alfred Baker 27th Annual Highlights of Recent Scientific Liver Meetings: Impact on Clinical Practice 2024 provides an efficient and comprehensive review of the most important advances in modern hepatology. By combining updates on MASH, liver fibrosis, alcohol-associated liver disease, portal hypertension, liver cancer, and transplantation, this course equips clinicians with practical knowledge to improve the diagnosis, treatment, and long-term management of patients with liver disease.

4. Topics

Topics (7 Lectures):

1. Non-Invasive Testing

2. MASH

3. Alcohol Associated Liver Disease

4. Liver Malignancies

5. Liver Transplantation

6. Portal Hypertension Cases

7. Primary Biliary Cholangitis – New Treatment Options